American Association for Cancer Research

AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship

 Charis Eng, M.D., Ph.D. 17th Annual Award Recipient
Charis Eng, M.D., Ph.D., FACP
Sondra J. and Stephen R. Hardis Endowed Chair
Cancer Genomic Medicine
Founding Director of the Genomic Medicine Institute
Cleveland Clinic’s Lerner Research Institute
Cleveland, Ohio


Dr. Eng will deliver her award lecture title PTEN Hamartoma Tumor Syndrome Previvorship: What Now? at the Annual Meeting 2014 in San Diego, Calif. The award ceremony and lecture will be held on Saturday, April 5, 2014, from 5:15 to 6:30 p.m. in the San Diego Convention Center. Visit the AACR Annual Meeting 2014 page for more information.


The Lectureship

The AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship was established in 1998 in honor of renowned virologist and discoverer of the Friend virus, Dr. Charlotte Friend, for her pioneering research on viruses, cell differentiation and cancer. The lecture is intended to give recognition to an outstanding female or male scientist who has made meritorious contributions to the field of cancer research and who has, through leadership or by example, furthered the advancement of women in science.

The recipient of the award will receive an honorarium of $5,000, give a 50-minute lecture during the AACR Annual Meeting 2014 in San Diego, Calif. (April 5-9, 2014), and will be provided support for the recipient and a guest to attend the AACR Annual Meeting 2014.

Eligibility

  • Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry, or government.
  • The lectureship will be presented to an individual investigator.
  • Institutions or organizations are not eligible for the lectureship.

Nomination Process

Nominations are closed.

Nominations may be made by any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Candidates may not nominate themselves.

Selection

Candidates will be considered by a Selection Committee of international cancer leaders appointed by the president of the AACR. After careful deliberations by the committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision. Selection of the winner will be made on the basis of the candidate's contributions to the field of cancer research and to the advancement of women in science. No regard will be given to age, race, gender, nationality, geographic location, or religious or political views.

Questions?

Linda Stokes, Program Associate
awards@aacr.org

American Association for Cancer Research
615 Chestnut Street, 17th Floor
Philadelphia, PA 19106-4404

SPOTLIGHT

Charis Eng, M.D., Ph.D.

17th Annual Award Recipient
Charis Eng, M.D., Ph.D., FACP 

Sondra J. and Stephen R. Hardis Endowed Chair
Cancer Genomic Medicine
Founding Director of the Genomic Medicine Institute
Cleveland Clinic’s Lerner Research Institute
Cleveland, Ohio


Dr. Charis Eng is recognized for her unstinting support and active promotion of women working in cancer research, medicine, and genetics.

Throughout her career, Dr. Eng has mentored scientists and budding scientists, from high school students, to postdoctoral fellows, to junior faculty. Many of her mentees are now in leadership roles in clinical and research institutions around the world and have themselves been awarded numerous prestigious fellowships, honors, and awards.

Dr. Eng is also renowned for her important research discoveries, particularly her efforts to identify, characterize, and understand genes that cause susceptibility to inherited cancer syndromes and to determine how these genes can be used to develop new clinical applications. For example, she was the founding chair of the International Cowden Consortium, which mapped and identified the PTEN tumor suppressor gene as the susceptibility gene for Cowden syndrome, and her laboratory continues to investigate the ways in which PTEN inactivation occurs in different cancers and to look for novel approaches to targeting it for therapy and prevention. Her work has been published in more than 400 peer-reviewed publications.
 

After receiving her doctorate and medical degrees from the University of Chicago, which she entered at the age of 16, Dr. Eng completed her residency in Boston, Mass., at Beth Israel Deaconess Medical Center, where she specialized in internal medicine, and trained in medical oncology at Dana-Farber Cancer Institute. She formally trained in clinical cancer genetics under the guidance of Sir Bruce A.J. Ponder, MB.BChir., Ph.D., during her fellowship at the University of Cambridge and the Royal Marsden NHS Trust in the United Kingdom. Following her training and prior to her position with the Cleveland Clinic, she worked at Dana-Farber and The Ohio State University in Columbus.

Dr. Eng has been recognized with numerous other accolades throughout her career, including the Doris Duke Clinical Scientist Award, the American Cancer Society Clinical Research Professorship, and election to the Institute of Medicine of the National Academies, the American Society of Clinical Investigation, and the American Association of Physician. She was appointed to the Advisory Committee on Genetics, Health, and Society by U.S. Health and Human Services Secretary Kathleen Sebelius in 2009.